Medtronic (MDT) Misses Q4 EPS by 5c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities
May 27, 2022 8:09 AM EDTTruist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.
The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More
Medtronic, Inc. (MDT) PT Lowered to $117 at Cowen; FY23 Can Be a Year of Real Pipeline Progress
May 27, 2022 6:21 AM EDTCowen analyst Joshua Jennings lowered the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $125.00) while maintaining an Outperform rating following earnings. Despite weak guidance, the analyst said FY23 can be a year of real pipeline progress.
The analyst commented, "MDT delivered... More
Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel
May 27, 2022 6:13 AM EDTStifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $125.00 (from $128.00) while maintaining a Buy rating.
The analyst commented, "Yes. We had hoped that Medtronics F4Q22 (Apr.) would show more visibly-positive signs of CEO Geoff Marthas positive... More
